Coronavirus Vaccine Study
- All
- News
- Videos
- Web Stories
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Omicron Infection Turbo-Charges Immunity In Vaccinated, Claim Early Studies
People who are vaccinated and then get infected with omicron may be primed to overcome a broad range of coronavirus variants, early research suggests.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Strong Protection For Babies Born To Covid-Vaccinated Moms: US Study
Babies born to mothers fully vaccinated against the coronavirus during pregnancy were around 60 percent less likely to be hospitalized with severe Covid, a new study by the US Centers for Disease Control and Prevention said Tuesday.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Hospitalisation Much Lower During Third Wave: Top Delhi Hospital's Study
A comparative study of all admitted COVID-19 patients in Max Healthcare hospitals suggests that during the ongoing third wave, occupancy of ICU beds and oxygen requirement is not higher compared to the prior two waves of the coronavirus infection.
-
Covid Vaccines Show High Efficacy Against Severe Omicron: US Data
Covid-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed Friday.
-
Covaxin Has Excellent Safety Record: Bharat Biotech On Study Citing Risks
The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Omicron Infection Turbo-Charges Immunity In Vaccinated, Claim Early Studies
People who are vaccinated and then get infected with omicron may be primed to overcome a broad range of coronavirus variants, early research suggests.
-
Covaxin, Covishield Recipients Had Same Infection Rate In 3rd Wave: Study
Seventy per cent of people who received a booster dose of Covid vaccine did not get infected during the third wave, according to a new study that covered around 6,000 people in India.
-
Mix-And-Match Of Booster Shot Offers Best Protection Against Covid: Study
Giving a different vaccine as the third dose than was received for the first two shots leads to better performance compared to using the booster of same preventive, according to a study published in The Lancet Global Health journal.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Strong Protection For Babies Born To Covid-Vaccinated Moms: US Study
Babies born to mothers fully vaccinated against the coronavirus during pregnancy were around 60 percent less likely to be hospitalized with severe Covid, a new study by the US Centers for Disease Control and Prevention said Tuesday.
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
Hospitalisation Much Lower During Third Wave: Top Delhi Hospital's Study
A comparative study of all admitted COVID-19 patients in Max Healthcare hospitals suggests that during the ongoing third wave, occupancy of ICU beds and oxygen requirement is not higher compared to the prior two waves of the coronavirus infection.
-
Covid Vaccines Show High Efficacy Against Severe Omicron: US Data
Covid-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed Friday.
